4.8 Article

N-6-Methyladenosine methyltransferase ZCCHC4 mediates ribosomal RNA methylation

期刊

NATURE CHEMICAL BIOLOGY
卷 15, 期 1, 页码 88-+

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/s41589-018-0184-3

关键词

-

资金

  1. National Institutes of Health [HG008935, GM113194]
  2. National Natural Science Foundation of China [81602513]
  3. Fudan University
  4. Postdoctoral International Exchange Program of the China Postdoctoral Council (CPC)
  5. National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health [1K01 DK111764]
  6. NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RM1HG008935] Funding Source: NIH RePORTER
  7. NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK111764] Funding Source: NIH RePORTER
  8. NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM113194] Funding Source: NIH RePORTER

向作者/读者索取更多资源

N-6-Methyladenosine (m(6)A) RNA modification is present in messenger RNAs (mRNA), ribosomal RNAs (rRNA), and spliceosomal RNAs (snRNA) in humans. Although mRNA m(6)A modifications have been extensively studied and shown to play critical roles in many cellular processes, the identity of m(6)A methyltransferases for rRNAs and the function of rRNA m(6)A modifications are unknown. Here we report a new m(6)A methyltransferase, ZCCHC4, which primarily methylates human 28S rRNA and also interacts with a subset of mRNAs. ZCCHC4 knockout eliminates m 6 A4220 modification in 28S rRNA, reduces global translation, and inhibits cell proliferation. We also find that ZCCHC4 protein is overexpressed in hepatocellular carcinoma tumors, and ZCCHC4 knockout significantly reduces tumor size in a xenograft mouse model. Our results highlight the functional significance of an rRNA m(6)A modification in translation and in tumor biology.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据